Reduced expression of arrestin beta 2 by graft monocytes during acute rejection of rat kidneys

Immunobiology

Volumn 216, Issue 7, 2011, Pages 854-861

  Zakrzewicz, Anna ^a   Krasteva, Gabriela ^a   Wilhelm, Jochen ^a   Dietrich, Hartmut ^a   Wilker, Sigrid ^a   Padberg, Winfried ^a   Wygrecka, Malgorzata ^a   Grau, Veronika ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Arrestin beta 2; Intravascular leukocytes; Kidney transplantation; NF kappaB; Organ rejection

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; ARRESTINS; CELL SEPARATION; DOWN-REGULATION; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MODELS, ANIMAL; MONOCYTES; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 79957624028     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.11.005     Document Type: Article

References (50)

1. Adams S., van der Laan L.J., Vernon-Wilson E., Renardel de Lavalette C., Dopp E.A., Dijkstra C.D., Simmons D.L., van den Berg T.K. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J. Immunol. 1998, 161:1853-1859.
2. Al-Lamki R.S., Bradley J.R., Pober J.S. Endothelial cells in allograft rejection. Transplantation 2008, 86:1340-1348.
3. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2002, 2:401-409.
4. Blackwell T.S., Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell. Mol. Biol. 1997, 17:3-9.
5. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
6. Damoiseaux J.G., Dopp E.A., Beelen R.H., Dijkstra C.D. Rat bone marrow and monocyte cultures: influence of culture time and lymphokines on the expression of macrophage differentiation antigens. J. Leukoc. Biol. 1989, 46:246-253.
7. Damoiseaux J.G., Dopp E.A., Neefjes J.J., Beelen R.H., Dijkstra C.D. Heterogeneity of macrophages in the rat evidenced by variability in determinants: two new anti-rat macrophage antibodies against a heterodimer of 160 and 95kd (CD11/CD18). J. Leukoc. Biol. 1989, 46:556-564.
8. Duan L., Wang C.Y., Chen J., Gong Q., Zhu P., Zheng F., Tan Z., Gong F., Fang M. High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response. Lab. Invest. 2010.
9. Fabre J., Lim S.H., Morris P.J. Renal transplantation in the rat: details of a technique. Aust. N Z J. Surg. 1971, 41:69-75.
10. Ferenbach D., Kluth D.C., Hughes J. Inflammatory cells in renal injury and repair. Semin. Nephrol. 2007, 27:250-259.
11. Gao H., Sun Y., Wu Y., Luan B., Wang Y., Qu B., Pei G. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell. 2004, 14:303-317.
12. Grau V., Herbst B., Steiniger B. Dynamics of monocytes/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res. 1998, 291:117-126.
13. Grau V., Stehling O., Garn H., Steiniger B. Accumulating monocytes in the vasculature of rat renal allografts: phenotype, cytokine, inducible no synthase, and tissue factor mRNA expression. Transplantation 2001, 71:37-46.
14. Holler J., Zakrzewicz A., Kaufmann A., Wilhelm J., Fuchs-Moll G., Dietrich H., Padberg W., Kuncova J., Kummer W., Grau V. Neuropeptide Y is expressed by rat mononuclear blood leukocytes and strongly down-regulated during inflammation. J. Immunol. 2008, 181:6906-6912.
15. Joosten S.A., van Kooten C., Paul L.C. Pathogenesis of chronic allograft rejection. Transplant Int. 2003, 16:137-145.
16. Jose M.D., Le Meur Y., Atkins R.C., Chadban S.J. Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am. J. Transplant. 2003, 3:294-300.
17. Kapahi P., Takahashi T., Natoli G., Adams S.R., Chen Y., Tsien R.Y., Karin M. Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J. Biol. Chem. 2000, 275:36062-36066.
18. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18:621-663.
19. Kizaki T., Izawa T., Sakurai T., Haga S., Taniguchi N., Tajiri H., Watanabe K., Day N.K., Toba K., Ohno H. Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2. Immunology 2008, 124:348-356.
20. Kluth D.C., Erwig L.P., Rees A.J. Multiple facets of macrophages in renal injury. Kidney Int. 2004, 66:542-557.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
22. Lattin J., Zidar D.A., Schroder K., Kellie S., Hume D.A., Sweet M.J. G-protein-coupled receptor expression, function, and signaling in macrophages. J. Leukoc. Biol. 2007, 82:16-32.
23. Lefkowitz R.J., Rajagopal K., Whalen E.J. New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol. Cell. 2006, 24:643-652.
24. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308:512-517.
25. Leichtman A.B., Cohen D., Keith D., O'Connor K., Goldstein M., McBride V., Gould C.J., Christensen L.L., Ashby V.B. Kidney and pancreas transplantation in the United States, 1997-2006: the HRSA Breakthrough Collaboratives and the 58 DSA Challenge. Am. J. Transplant. 2008, 8:946-957.
26. Luttrell L.M., Ferguson S.S., Daaka Y., Miller W.E., Maudsley S., Della Rocca G.J., Lin F., Kawakatsu H., Owada K., Luttrell D.K., Caron M.G., Lefkowitz R.J. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999, 283:655-661.
27. Luttrell L.M., Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell. Sci. 2002, 115:455-465.
28. Ma L., Pei G. Beta-arrestin signaling and regulation of transcription. J. Cell. Sci. 2007, 120:213-218.
29. McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E., Lin F.T., Davis R.J., Lefkowitz R.J. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 2000, 290:1574-1577.
30. Moosig F., Damm F., Knorr-Spahr A., Ritgen M., Zeuner R.A., Kneba M., Ernst M., Schroder J.O. Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 2006, 146:409-416.
31. Oakley R.H., Laporte S.A., Holt J.A., Caron M.G., Barak L.S. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 2000, 275:17201-17210.
32. Qi F., Adair A., Ferenbach D., Vass D.G., Mylonas K.J., Kipari T., Clay M., Kluth D.C., Hughes J., Marson L.P. Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 2008, 86:1267-1274.
33. Raghuwanshi S.K., Nasser M.W., Chen X., Strieter R.M., Richardson R.M. Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J. Immunol. 2008, 180:5699-5706.
34. Reinders M.E., Rabelink T.J., Briscoe D.M. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J. Am. Soc. Nephrol. 2006, 17:932-942.
35. Scriba A., Luciano L., Steiniger B. High-yield purification of rat monocytes by combined density gradient and immunomagnetic separation. J. Immunol. Methods 1996, 189:203-216.
36. Shenoy S.K., Lefkowitz R.J. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J. 2003, 375:503-515.
37. Shi Y., Feng Y., Kang J., Liu C., Li Z., Li D., Cao W., Qiu J., Guo Z., Bi E., Zang L., Lu C., Zhang J.Z., Pei G. Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat. Immunol. 2007, 8:817-824.
38. Stehling O., Grau V., Steiniger B. Cytotoxicity of normal and activated rat monocytes analyzed by flow cytometry. Cytometry A 2003, 56:81-88.
39. Stehling O., Grau V., Steiniger B. Monocyte cytotoxicity during acute kidney graft rejection in rats. Int. Immunol. 2004, 16:101-110.
40. Steiniger B., Stehling O., Scriba A., Grau V. Monocytes in the rat: phenotype and function during acute allograft rejection. Immunol. Rev. 2001, 184:38-44.
41. Tergaonkar V. NFkappaB pathway: a good signaling paradigm and therapeutic target. Int. J. Biochem. Cell. Biol. 2006, 38:1647-1653.
42. Tipping P.G., Holdsworth S.R. T cells in glomerulonephritis. Springer Semin. Immunopathol. 2003, 24:377-393.
43. Tohgo A., Choy E.W., Gesty-Palmer D., Pierce K.L., Laporte S., Oakley R.H., Caron M.G., Lefkowitz R.J., Luttrell L.M. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J. Biol. Chem. 2003, 278:6258-6267.
44. van Furth R., Sluiter W. Distribution of blood monocytes between a marginating and a circulating pool. J. Exp. Med. 1986, 163:474-479.
45. Walker J.K., Fong A.M., Lawson B.L., Savov J.D., Patel D.D., Schwartz D.A., Lefkowitz R.J. Beta-arrestin-2 regulates the development of allergic asthma. J. Clin. Invest. 2003, 112:566-574.
46. Wang P., Wu Y., Ge X., Ma L., Pei G. Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J. Biol. Chem. 2003, 278:11648-11653.
47. Wang Y., Tang Y., Teng L., Wu Y., Zhao X., Pei G. Association of beta-arrestin and TRAF6 negatively regulates toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 2006, 7:139-147.
48. Wei J.F., Zheng S.S. NF-kappa B in allograft rejection. Hepatobiliary Pancreat. Dis. Int. 2003, 2:180-183.
49. Witherow D.S., Garrison T.R., Miller W.E., Lefkowitz R.J. beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8603-8607.
50. Xiao K., McClatchy D.B., Shukla A.K., Zhao Y., Chen M., Shenoy S.K., Yates J.R., Lefkowitz R.J. Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12011-12016.